New Pancreatic Cancer Guidelines for Patients Available from NCCN
The National Comprehensive Cancer Network® (NCCN®), with the support of the Pancreatic Cancer Action Network, announces the latest addition to the library of NCCN Guidelines for Patients™, patient-friendly translations of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). The NCCN Guidelines for Patients™: Pancreatic Cancer is now available free of charge at NCCN.com and NCCN.org.
The NCCN Guidelines for Patients™ are designed to provide people with cancer and their caregivers with state-of-the-art treatment information in easy-to-understand language. According to the National Cancer Institute (NCI), because of the nature of its symptoms, pancreatic cancer is often detected in the later stages of the disease; therefore, it is critical to provide resources which can help patients take a more active role in the management of their care.
The NCCN Guidelines for Patients™: Pancreatic Cancer is dedicated to patients diagnosed with any stage of the disease and is supported by the Pancreatic Cancer Action Network, a patient-based advocacy agency dedicated to advancing research, supporting patients, and creating hope for those affected by pancreatic cancer.
"We are proud to collaborate with NCCN on the creation of the patient guidelines for pancreatic cancer and incorporate them into our cadre of materials offered to patients and families through our Patient and Liaison Services program," said Julie Fleshman, President and Chief Executive Officer at the Pancreatic Cancer Action Network. "The Pancreatic Cancer Action Network is committed to creating hope for those affected by the disease through research, patient support, and advocacy for a cure. These guidelines offer patients a new tool to better understand their diagnoses and take an active role in their own treatment."
The NCCN Guidelines for Patients™: Pancreatic Cancer was also made possible through an anonymous donation in the name of Dr. Randy Pausch, Professor of Computer Science, Human Computer Interaction, and Design at Carnegie Mellon University, whose famous Last Lecture was transcribed into an international bestselling book. Dr. Pausch was diagnosed with pancreatic cancer in 2007 and died in 2009. The NCCN Guidelines for Patients™: Pancreatic Cancer is dedicated to the memory of Dr. Randy Pausch.
In announcing the publication of the NCCN Guidelines for Patients™, NCCN's Executive Vice President and Chief Operating Officer Patricia Goldsmith acknowledged the importance of making this information available to the public. "I'm pleased to announce the availability of the NCCN Guidelines for Patients for pancreatic cancer. The NCCN Foundation is committed to making resources like the pancreatic cancer guidelines for patients readily available to empower patients and their caregivers. With generous support and collaboration from organizations like the Pancreatic Cancer Action Network and private donors, NCCN continues to provide authoritative information and recommendations to people with cancer as quickly and effectively as possible," said Ms. Goldsmith.
The NCCN Guidelines® are developed by multidisciplinary panels of experts from NCCN Member Institutions and feature algorithms or "decision trees" that address every appropriate management option from initial work-up throughout the course of the disease. The NCCN Guidelines for Patients™ translate the professional guidelines in a clear, step-by-step manner that people can use as the basis for making decisions and discussing treatment options with their physicians.
NCCN offers 10 other NCCN Guidelines for Patients™, including Breast, Colon, Non-Small Cell Lung, Ovarian and Prostate Cancers, Chronic Myelogenous Leukemia, Malignant Pleural Mesothelioma, Melanoma, Multiple Myeloma, and Lung Cancer Screening. Additional NCCN Guidelines for Patients™ will be available throughout 2012.
About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 21 of the world's leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers. The primary goal of all NCCN initiatives is to improve the quality, effectiveness, and efficiency of oncology practice so patients can live better lives.
The NCCN Member Institutions are: City of Hope Comprehensive Cancer Center, Los Angeles, CA; Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center, Boston, MA; Duke Cancer Institute, Durham, NC; Fox Chase Cancer Center, Philadelphia, PA; Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL; Memorial Sloan-Kettering Cancer Center, New York, NY; Moffitt Cancer Center, Tampa, FL; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH; Roswell Park Cancer Institute, Buffalo, NY; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO; St. Jude Children's Research Hospital/University of Tennessee Cancer Institute, Memphis, TN; Stanford Cancer Institute, Stanford, CA; University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; UNMC Eppley Cancer Center at The Nebraska Medical Center, Omaha, NE; The University of Texas MD Anderson Cancer Center, Houston, TX; and Vanderbilt-Ingram Cancer Center, Nashville, TN.
Clinicians, visit NCCN.org. Patients and caregivers, visit NCCN.com.
About the Pancreatic Cancer Action Network
The Pancreatic Cancer Action Network is the national organization creating hope in a comprehensive way through research, patient support, community outreach and advocacy for a cure. The organization is leading the way to increase the survival rate for people diagnosed with this devastating disease through a bold initiative – The Vision of Progress: Double the Pancreatic Cancer Survival Rate by 2020. Together, we can know, fight and end pancreatic cancer by intensifying our efforts to heighten awareness, raise funds for comprehensive private research, and advocate for dedicated federal research to advance early diagnostics, better treatments and increase chances of survival.
For more information about the Pancreatic Cancer Action Network, visit pancan.org.
About Dr. Randy Pausch
Dr. Randy Pausch was a Professor of Computer Science, Human Computer Interaction, and Design at Carnegie Mellon University. From 1988 to 1997, he taught at the University of Virginia. He was an award-winning teacher and researcher, worked with Adobe, Google, Electronic Arts (EA), and Walt Disney Imagineering, and pioneered the non-profit Alice project. (Alice is an innovative 3-D environment that teaches programming to young people via storytelling and interactive game-playing.) He also co-founded The Entertainment Technology Center at Carnegie Mellon with Don Marinelli. Randy died as a result of complications from pancreatic cancer on July 25, 2008.
For more information about Dr. Randy Pausch, visit Thelastlecture.com.